Approvals/TGA/IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Approved

STANDARD

IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Accord Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dc09e15e52b7dcd0
Product Name: IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Artg Id: 316413
Artg Name: IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Sponsor: Accord Healthcare Pty Ltd
Company Detail Path: /organization/accord-healthcare-pty-ltd
Artg Date: 2020-03-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

dc09e15e52b7dcd0

Type

Standard